Sinocelltech

About:

Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.

Website: http://www.sinocelltech.com/

Top Investors: Qiming Venture Partners

Description:

Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines. It has developed platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The company is driven by a mission to make life-saving biological medicines available to ordinary people with ever-improving process and manufacturing technologies to drive down the cost of product development and production.

Total Funding Amount:

200M CNY

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2007-01-01

Contact Email:

BD(AT)sinocelltech.com

Founders:

Liangzhi Xie

Number of Employees:

51-100

Last Funding Date:

2017-05-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai